BRAF and melanoma: In an additional experiment, it was shown that a BRAF mutant devoid of kinase activity mimics the effect of BRAF inhibitors, and therefore, the kinase-dead BRAF mutant cooperates with oncogenic NRAS to induce melanoma in mice [13].